APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nocturia

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nocturia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017460328 December 2025197 pages

Choose your research edition.

Industry ResearchNocturia Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nocturia Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Nocturia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nocturia Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Nocturia Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Nocturia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nocturia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nocturia include Abbott, Allergan, APOTEX INC, Astellas Pharma, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Ferring Pharmaceuticals and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nocturia market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nocturia and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nocturia revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nocturia market size, projected growth trends, production technologies, key applications, and end-use industries.

Nocturia Segment by Company

Abbott

Allergan

APOTEX INC

Astellas Pharma

Astra Zeneca

Bristol-Myers Squibb

Eli Lilly

Ferring Pharmaceuticals

GlaxoSmithKline

Johnson & Johnson

Merck

Mylan

Novartis

Pfizer

Rechon Life Science AB

Sagent Pharmaceuticals

Sanofi

Sun Pharmaceutical Industries Ltd.

Teva

Chengdu Leer Pharmaceutical

Fosun Pharma

Hainan Zhonghe Pharmaceutical

Nanjing Xingyin Pharmaceutical Group

Hybio Pharmaceutical

Zhejiang Conba Pharmaceutical

Nocturia Segment by Type

Desmopressin

Diuretics

Anticholinergic Drugs

Alpha Blockers

Others

Nocturia Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Nocturia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nocturia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nocturia industry.

Chapter 3: Detailed analysis of Nocturia companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nocturiarevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Desmopressin Table 3. Key Players of Diuretics Table 4. Key Players of Anticholinergic Drugs Table 3. Key Players of Alpha Blockers Table 4. Key Players of Others Table 5. Global Nocturia Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Retail Pharmacies Table 7. Key Players of Online Pharmacies Table 8. Key Players of Hospital Pharmacies Table 9. Global Nocturia Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Nocturia Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Nocturia Market Share by Region (2021-2026) Table 12. Global Nocturia Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Nocturia Market Share by Region (2027-2032) Table 14. Nocturia Industry Trends Table 15. Nocturia Industry Drivers Table 16. Nocturia Industry Opportunities and Challenges Table 17. Nocturia Industry Restraints Table 18. Global Nocturia Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Nocturia Revenue Market Share by Company (2021-2026) Table 20. Global Nocturia Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nocturia Key Company Head Office and Area Served Table 22. Global Nocturia Company, Product Type & Application Table 23. Global Nocturia Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Nocturia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Nocturia Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Nocturia Revenue Market Share by Type (2021-2026) Table 30. Global Nocturia Revenue Market Share by Type (2027-2032) Table 31. Global Nocturia Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Nocturia Revenue Market Share by Application (2021-2026) Table 35. Global Nocturia Revenue Market Share by Application (2027-2032) Table 36. Abbott Company Information Table 37. Abbott Business Overview Table 38. Abbott Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott Nocturia Product Portfolio Table 40. Abbott Recent Development Table 41. Allergan Company Information Table 42. Allergan Business Overview Table 43. Allergan Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Allergan Nocturia Product Portfolio Table 45. Allergan Recent Development Table 46. APOTEX INC Company Information Table 47. APOTEX INC Business Overview Table 48. APOTEX INC Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. APOTEX INC Nocturia Product Portfolio Table 50. APOTEX INC Recent Development Table 51. Astellas Pharma Company Information Table 52. Astellas Pharma Business Overview Table 53. Astellas Pharma Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Astellas Pharma Nocturia Product Portfolio Table 55. Astellas Pharma Recent Development Table 56. Astra Zeneca Company Information Table 57. Astra Zeneca Business Overview Table 58. Astra Zeneca Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Astra Zeneca Nocturia Product Portfolio Table 60. Astra Zeneca Recent Development Table 61. Bristol-Myers Squibb Company Information Table 62. Bristol-Myers Squibb Business Overview Table 63. Bristol-Myers Squibb Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bristol-Myers Squibb Nocturia Product Portfolio Table 65. Bristol-Myers Squibb Recent Development Table 66. Eli Lilly Company Information Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Eli Lilly Nocturia Product Portfolio Table 70. Eli Lilly Recent Development Table 71. Ferring Pharmaceuticals Company Information Table 72. Ferring Pharmaceuticals Business Overview Table 73. Ferring Pharmaceuticals Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Ferring Pharmaceuticals Nocturia Product Portfolio Table 75. Ferring Pharmaceuticals Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GlaxoSmithKline Nocturia Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Johnson & Johnson Nocturia Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Merck Nocturia Product Portfolio Table 90. Merck Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Mylan Nocturia Product Portfolio Table 95. Mylan Recent Development Table 96. Novartis Company Information Table 97. Novartis Business Overview Table 98. Novartis Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Novartis Nocturia Product Portfolio Table 100. Novartis Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Pfizer Nocturia Product Portfolio Table 105. Pfizer Recent Development Table 106. Rechon Life Science AB Company Information Table 107. Rechon Life Science AB Business Overview Table 108. Rechon Life Science AB Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Rechon Life Science AB Nocturia Product Portfolio Table 110. Rechon Life Science AB Recent Development Table 111. Sagent Pharmaceuticals Company Information Table 112. Sagent Pharmaceuticals Business Overview Table 113. Sagent Pharmaceuticals Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Sagent Pharmaceuticals Nocturia Product Portfolio Table 115. Sagent Pharmaceuticals Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Sanofi Nocturia Product Portfolio Table 120. Sanofi Recent Development Table 121. Sun Pharmaceutical Industries Ltd. Company Information Table 122. Sun Pharmaceutical Industries Ltd. Business Overview Table 123. Sun Pharmaceutical Industries Ltd. Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Sun Pharmaceutical Industries Ltd. Nocturia Product Portfolio Table 125. Sun Pharmaceutical Industries Ltd. Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Teva Nocturia Product Portfolio Table 130. Teva Recent Development Table 131. Chengdu Leer Pharmaceutical Company Information Table 132. Chengdu Leer Pharmaceutical Business Overview Table 133. Chengdu Leer Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Chengdu Leer Pharmaceutical Nocturia Product Portfolio Table 135. Chengdu Leer Pharmaceutical Recent Development Table 136. Fosun Pharma Company Information Table 137. Fosun Pharma Business Overview Table 138. Fosun Pharma Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Fosun Pharma Nocturia Product Portfolio Table 140. Fosun Pharma Recent Development Table 141. Hainan Zhonghe Pharmaceutical Company Information Table 142. Hainan Zhonghe Pharmaceutical Business Overview Table 143. Hainan Zhonghe Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. Hainan Zhonghe Pharmaceutical Nocturia Product Portfolio Table 145. Hainan Zhonghe Pharmaceutical Recent Development Table 146. Nanjing Xingyin Pharmaceutical Group Company Information Table 147. Nanjing Xingyin Pharmaceutical Group Business Overview Table 148. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. Nanjing Xingyin Pharmaceutical Group Nocturia Product Portfolio Table 150. Nanjing Xingyin Pharmaceutical Group Recent Development Table 151. Hybio Pharmaceutical Company Information Table 152. Hybio Pharmaceutical Business Overview Table 153. Hybio Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. Hybio Pharmaceutical Nocturia Product Portfolio Table 155. Hybio Pharmaceutical Recent Development Table 156. Zhejiang Conba Pharmaceutical Company Information Table 157. Zhejiang Conba Pharmaceutical Business Overview Table 158. Zhejiang Conba Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 159. Zhejiang Conba Pharmaceutical Nocturia Product Portfolio Table 160. Zhejiang Conba Pharmaceutical Recent Development Table 161. North America Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 162. North America Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 163. North America Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 164. North America Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 165. North America Nocturia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Nocturia Market Size by Country (2021-2026) Table 167. North America Nocturia Market Size by Country (2027-2032) Table 168. Europe Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 169. Europe Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 170. Europe Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 171. Europe Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 172. Europe Nocturia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Nocturia Market Size by Country (2021-2026) Table 174. Europe Nocturia Market Size by Country (2027-2032) Table 175. China Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 176. China Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 177. China Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 178. China Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 179. Asia Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 180. Asia Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 181. Asia Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 182. Asia Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 183. Asia Nocturia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Nocturia Market Size by Country (2021-2026) Table 185. Asia Nocturia Market Size by Country (2027-2032) Table 186. South America, Middle East & Africa Nocturia Market Size by Type (2021-2026) & (US$ Million) Table 187. South America, Middle East & Africa Nocturia Market Size by Type (2027-2032) & (US$ Million) Table 188. South America, Middle East & Africa Nocturia Market Size by Application (2021-2026) & (US$ Million) Table 189. South America, Middle East & Africa Nocturia Market Size by Application (2027-2032) & (US$ Million) Table 190. South America, Middle East & Africa Nocturia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. South America, Middle East & Africa Nocturia Market Size by Country (2021-2026) Table 192. South America, Middle East & Africa Nocturia Market Size by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Nocturia Product Image Figure 2. Global Nocturia Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nocturia Market Share by Type: 2025 VS 2032 Figure 4. Desmopressin Image Figure 5. Diuretics Image Figure 6. Anticholinergic Drugs Image Figure 7. Alpha Blockers Image Figure 8. Others Image Figure 9. Global Nocturia Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Nocturia Market Share by Application: 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global Nocturia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nocturia Market Size (2021-2032) & (US$ Million) Figure 16. Global Nocturia Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nocturia Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nocturia Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nocturia Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nocturia Revenue Market Share by Type (2021-2032) Figure 23. Global Nocturia Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nocturia Revenue Market Share by Application (2021-2032) Figure 25. North America Nocturia Market Size (2021-2032) & (US$ Million) Figure 26. North America Nocturia Market Share by Type (2021-2032) Figure 27. North America Nocturia Market Share by Application (2021-2032) Figure 28. North America Nocturia Market Share by Country (2021-2032) Figure 29. United States Nocturia Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nocturia Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nocturia Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nocturia Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nocturia Market Share by Type (2021-2032) Figure 34. Europe Nocturia Market Share by Application (2021-2032) Figure 35. Europe Nocturia Market Share by Country (2021-2032) Figure 36. Germany Nocturia Market Size (2021-2032) & (US$ Million) Figure 37. France Nocturia Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nocturia Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nocturia Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nocturia Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nocturia Market Size (2021-2032) & (US$ Million) Figure 42. China Nocturia Market Size (2021-2032) & (US$ Million) Figure 43. China Nocturia Market Share by Type (2021-2032) Figure 44. China Nocturia Market Share by Application (2021-2032) Figure 45. Asia Nocturia Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nocturia Market Share by Type (2021-2032) Figure 47. Asia Nocturia Market Share by Application (2021-2032) Figure 48. Asia Nocturia Market Share by Country (2021-2032) Figure 49. Japan Nocturia Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nocturia Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nocturia Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nocturia Market Size (2021-2032) & (US$ Million) Figure 53. India Nocturia Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nocturia Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nocturia Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nocturia Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nocturia Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nocturia Market Share by Country (2021-2032) Figure 59. Brazil Nocturia Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nocturia Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nocturia Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nocturia Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nocturia Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nocturia Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nocturia Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nocturia Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Desmopressin
  • Diuretics
  • Anticholinergic Drugs
  • Alpha Blockers
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Abbott
  • Allergan
  • APOTEX INC
  • Astellas Pharma
  • Astra Zeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Ferring Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Mylan
  • Novartis
  • Pfizer
  • Rechon Life Science AB
  • Sagent Pharmaceuticals
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva
  • Chengdu Leer Pharmaceutical
  • Fosun Pharma
  • Hainan Zhonghe Pharmaceutical
  • Nanjing Xingyin Pharmaceutical Group
  • Hybio Pharmaceutical
  • Zhejiang Conba Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nocturia Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Desmopressin
  5. 1.2.3 Diuretics
  6. 1.2.4 Anticholinergic Drugs
  7. 1.2.5 Alpha Blockers
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Nocturia Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nocturia Growth Trends by Region
  16. 1.5.1 Global Nocturia Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nocturia Market Size by Region (2021-2026)
  18. 1.5.3 Nocturia Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nocturia Market Dynamics
  1. 2.1 Nocturia Industry Trends
  2. 2.2 Nocturia Industry Drivers
  3. 2.3 Nocturia Industry Opportunities and Challenges
  4. 2.4 Nocturia Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nocturia Revenue by Company (2021-2026)
  2. 3.2 Global Nocturia Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nocturia Key Company Head office and Area Served
  4. 3.4 Global Nocturia Company, Product Type & Application
  5. 3.5 Global Nocturia Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nocturia Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nocturia Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nocturia Tier 1, Tier 2, and Tier 3
4 Nocturia Market by Type
  1. 4.1 Global Nocturia Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nocturia Market Size by Type (2021-2032)
  3. 4.3 Global Nocturia Market Size Share by Type (2021-2032)
5 Nocturia Market by Application
  1. 5.1 Global Nocturia Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nocturia Market Size by Application (2021-2032)
  3. 5.3 Global Nocturia Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Nocturia Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Allergan Nocturia Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 APOTEX INC
  14. 6.3.1 APOTEX INC Company Information
  15. 6.3.2 APOTEX INC Business Overview
  16. 6.3.3 APOTEX INC Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 APOTEX INC Nocturia Product Portfolio
  18. 6.3.5 APOTEX INC Recent Developments
  19. 6.4 Astellas Pharma
  20. 6.4.1 Astellas Pharma Company Information
  21. 6.4.2 Astellas Pharma Business Overview
  22. 6.4.3 Astellas Pharma Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Astellas Pharma Nocturia Product Portfolio
  24. 6.4.5 Astellas Pharma Recent Developments
  25. 6.5 Astra Zeneca
  26. 6.5.1 Astra Zeneca Company Information
  27. 6.5.2 Astra Zeneca Business Overview
  28. 6.5.3 Astra Zeneca Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Astra Zeneca Nocturia Product Portfolio
  30. 6.5.5 Astra Zeneca Recent Developments
  31. 6.6 Bristol-Myers Squibb
  32. 6.6.1 Bristol-Myers Squibb Company Information
  33. 6.6.2 Bristol-Myers Squibb Business Overview
  34. 6.6.3 Bristol-Myers Squibb Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Nocturia Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly Nocturia Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Ferring Pharmaceuticals
  44. 6.8.1 Ferring Pharmaceuticals Company Information
  45. 6.8.2 Ferring Pharmaceuticals Business Overview
  46. 6.8.3 Ferring Pharmaceuticals Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ferring Pharmaceuticals Nocturia Product Portfolio
  48. 6.8.5 Ferring Pharmaceuticals Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GlaxoSmithKline Nocturia Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Johnson & Johnson
  56. 6.10.1 Johnson & Johnson Company Information
  57. 6.10.2 Johnson & Johnson Business Overview
  58. 6.10.3 Johnson & Johnson Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Johnson & Johnson Nocturia Product Portfolio
  60. 6.10.5 Johnson & Johnson Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Merck Nocturia Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Mylan Nocturia Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Novartis
  74. 6.13.1 Novartis Company Information
  75. 6.13.2 Novartis Business Overview
  76. 6.13.3 Novartis Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Novartis Nocturia Product Portfolio
  78. 6.13.5 Novartis Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Pfizer Nocturia Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Rechon Life Science AB
  86. 6.15.1 Rechon Life Science AB Company Information
  87. 6.15.2 Rechon Life Science AB Business Overview
  88. 6.15.3 Rechon Life Science AB Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Rechon Life Science AB Nocturia Product Portfolio
  90. 6.15.5 Rechon Life Science AB Recent Developments
  91. 6.16 Sagent Pharmaceuticals
  92. 6.16.1 Sagent Pharmaceuticals Company Information
  93. 6.16.2 Sagent Pharmaceuticals Business Overview
  94. 6.16.3 Sagent Pharmaceuticals Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Sagent Pharmaceuticals Nocturia Product Portfolio
  96. 6.16.5 Sagent Pharmaceuticals Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sanofi Nocturia Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Sun Pharmaceutical Industries Ltd.
  104. 6.18.1 Sun Pharmaceutical Industries Ltd. Company Information
  105. 6.18.2 Sun Pharmaceutical Industries Ltd. Business Overview
  106. 6.18.3 Sun Pharmaceutical Industries Ltd. Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Sun Pharmaceutical Industries Ltd. Nocturia Product Portfolio
  108. 6.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  109. 6.19 Teva
  110. 6.19.1 Teva Company Information
  111. 6.19.2 Teva Business Overview
  112. 6.19.3 Teva Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Teva Nocturia Product Portfolio
  114. 6.19.5 Teva Recent Developments
  115. 6.20 Chengdu Leer Pharmaceutical
  116. 6.20.1 Chengdu Leer Pharmaceutical Company Information
  117. 6.20.2 Chengdu Leer Pharmaceutical Business Overview
  118. 6.20.3 Chengdu Leer Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Chengdu Leer Pharmaceutical Nocturia Product Portfolio
  120. 6.20.5 Chengdu Leer Pharmaceutical Recent Developments
  121. 6.21 Fosun Pharma
  122. 6.21.1 Fosun Pharma Company Information
  123. 6.21.2 Fosun Pharma Business Overview
  124. 6.21.3 Fosun Pharma Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Fosun Pharma Nocturia Product Portfolio
  126. 6.21.5 Fosun Pharma Recent Developments
  127. 6.22 Hainan Zhonghe Pharmaceutical
  128. 6.22.1 Hainan Zhonghe Pharmaceutical Company Information
  129. 6.22.2 Hainan Zhonghe Pharmaceutical Business Overview
  130. 6.22.3 Hainan Zhonghe Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Hainan Zhonghe Pharmaceutical Nocturia Product Portfolio
  132. 6.22.5 Hainan Zhonghe Pharmaceutical Recent Developments
  133. 6.23 Nanjing Xingyin Pharmaceutical Group
  134. 6.23.1 Nanjing Xingyin Pharmaceutical Group Company Information
  135. 6.23.2 Nanjing Xingyin Pharmaceutical Group Business Overview
  136. 6.23.3 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Nanjing Xingyin Pharmaceutical Group Nocturia Product Portfolio
  138. 6.23.5 Nanjing Xingyin Pharmaceutical Group Recent Developments
  139. 6.24 Hybio Pharmaceutical
  140. 6.24.1 Hybio Pharmaceutical Company Information
  141. 6.24.2 Hybio Pharmaceutical Business Overview
  142. 6.24.3 Hybio Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Hybio Pharmaceutical Nocturia Product Portfolio
  144. 6.24.5 Hybio Pharmaceutical Recent Developments
  145. 6.25 Zhejiang Conba Pharmaceutical
  146. 6.25.1 Zhejiang Conba Pharmaceutical Company Information
  147. 6.25.2 Zhejiang Conba Pharmaceutical Business Overview
  148. 6.25.3 Zhejiang Conba Pharmaceutical Nocturia Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Zhejiang Conba Pharmaceutical Nocturia Product Portfolio
  150. 6.25.5 Zhejiang Conba Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Nocturia Market Size (2021-2032)
  2. 7.2 North America Nocturia Market Size by Type
  3. 7.2.1 North America Nocturia Market Size by Type (2021-2026)
  4. 7.2.2 North America Nocturia Market Size by Type (2027-2032)
  5. 7.2.3 North America Nocturia Market Share by Type (2021-2032)
  6. 7.3 North America Nocturia Market Size by Application
  7. 7.3.1 North America Nocturia Market Size by Application (2021-2026)
  8. 7.3.2 North America Nocturia Market Size by Application (2027-2032)
  9. 7.3.3 North America Nocturia Market Share by Application (2021-2032)
  10. 7.4 North America Nocturia Market Size by Country
  11. 7.4.1 North America Nocturia Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nocturia Market Size by Country (2021-2026)
  13. 7.4.3 North America Nocturia Market Size by Country (2027-2032)
  14. 7.4.4 North America Nocturia Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nocturia Market Size (2021-2032)
  2. 8.2 Europe Nocturia Market Size by Type
  3. 8.2.1 Europe Nocturia Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nocturia Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nocturia Market Share by Type (2021-2032)
  6. 8.3 Europe Nocturia Market Size by Application
  7. 8.3.1 Europe Nocturia Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nocturia Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nocturia Market Share by Application (2021-2032)
  10. 8.4 Europe Nocturia Market Size by Country
  11. 8.4.1 Europe Nocturia Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nocturia Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nocturia Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nocturia Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nocturia Market Size (2021-2032)
  2. 9.2 China Nocturia Market Size by Type
  3. 9.2.1 China Nocturia Market Size by Type (2021-2026)
  4. 9.2.2 China Nocturia Market Size by Type (2027-2032)
  5. 9.2.3 China Nocturia Market Share by Type (2021-2032)
  6. 9.3 China Nocturia Market Size by Application
  7. 9.3.1 China Nocturia Market Size by Application (2021-2026)
  8. 9.3.2 China Nocturia Market Size by Application (2027-2032)
  9. 9.3.3 China Nocturia Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nocturia Market Size (2021-2032)
  2. 10.2 Asia Nocturia Market Size by Type
  3. 10.2.1 Asia Nocturia Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nocturia Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nocturia Market Share by Type (2021-2032)
  6. 10.3 Asia Nocturia Market Size by Application
  7. 10.3.1 Asia Nocturia Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nocturia Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nocturia Market Share by Application (2021-2032)
  10. 10.4 Asia Nocturia Market Size by Country
  11. 10.4.1 Asia Nocturia Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nocturia Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nocturia Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nocturia Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nocturia Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nocturia Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nocturia Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nocturia Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nocturia Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nocturia Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nocturia Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nocturia Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nocturia Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nocturia Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nocturia Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nocturia Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nocturia Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nocturia Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst